PROTHENA CORP PUBLIC LTD CO
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. OTHER INFORMATION
On March 3, 2025, David A. Ford, Chief People Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 10,250 shares of the Company’s ordinary shares until July 1, 2026.
On March 12, 2025, Carol D. Karp, Chief Regulatory Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 105,000 shares of the Company’s ordinary shares until June 15, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.